These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1596693)

  • 21. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
    Small DL; Bolzon BJ; Cheung DW
    Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of D-myo-inositol-1,2,6-trisphosphate on glucose-stimulated insulin secretion in the mouse.
    Ahrén B
    Neuropeptides; 1992 Mar; 21(3):163-6. PubMed ID: 1630602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.
    Xia J; Neild TO; Kotecha N
    Br J Pharmacol; 1992 Nov; 107(3):771-6. PubMed ID: 1472974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y (NPY) in the orbital arteries of the rabbit. Immunocytochemistry and vasomotor activity.
    Elsås T; Uddman R; Junping Y; Edvinsson L
    Acta Ophthalmol Scand; 1995 Dec; 73(6):517-20. PubMed ID: 9019375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eicosapentaenoic acid inhibits vasoconstrictor- and noradrenaline-potentiating effects of neuropeptide Y in the isolated rabbit ear.
    Juan H; Sametz W; Saria A; Pöch G
    J Auton Nerv Syst; 1988 Apr; 22(3):237-42. PubMed ID: 2843588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.
    Prieto D; Buus CL; Mulvany MJ; Nilsson H
    Br J Pharmacol; 2000 Apr; 129(8):1689-99. PubMed ID: 10780975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y-induced pressor responses in spontaneously hypertensive and Wistar-Kyoto rats antagonized by D-myo-inositol-1,2,6-triphosphate (PP56).
    Sun XY; Edvinsson L; Hedner T
    J Hypertens Suppl; 1991 Dec; 9(6):S344-5. PubMed ID: 1818993
    [No Abstract]   [Full Text] [Related]  

  • 28. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
    Potter EK; Edvinsson L; Gustafsson T
    Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.
    Smyth L; Bobalova J; Ward SM; Keef KD; Mutafova-Yambolieva VN
    Auton Neurosci; 2000 Dec; 86(1-2):18-29. PubMed ID: 11269921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
    Sun XY; Dahlöf C; Edvinsson L; Hedner T
    Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
    Gradin KA; Li JY; Andersson O; Simonsen U
    J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
    Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
    J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.
    Wahlestedt C; Yanaihara N; Håkanson R
    Regul Pept; 1986 Feb; 13(3-4):307-18. PubMed ID: 3010387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium inhibits the responses to neuropeptide Y in the rabbit coronary artery.
    Corr L; Burnstock G; Poole-Wilson P
    J Mol Cell Cardiol; 1991 Mar; 23(3):231-5. PubMed ID: 1880809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
    Hieble JP; Duesler JG; Daly RN
    J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of vascular endothelium in the potentiation of vasoconstrictor responses by neuropeptide Y.
    Hieble JP; Ruffolo RR; Daly RN
    J Hypertens Suppl; 1988 Dec; 6(4):S239-42. PubMed ID: 3241208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats.
    Sun XY; Feng QP; Zhao X; Edvinsson L; Hedner T
    Life Sci; 1995; 57(12):1197-211. PubMed ID: 7674809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered neuropeptide Y Y1 responses in mesenteric arteries in rats with congestive heart failure.
    Bergdahl A; Nilsson T; Sun XY; Hedner T; Edvinsson L
    Eur J Pharmacol; 1998 Nov; 360(2-3):165-73. PubMed ID: 9851583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.